Claims
- 1. A pharmaceutical composition comprising SYN3 in combination with a pharmaceutically acceptable carrier.
- 2. The pharmaceutical composition of claim 1, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 3. The pharmaceutical composition of claim 2, wherein said composition is lyophilized.
- 4. The lyophilized pharmaceutical composition of claim 3, wherein said composition further comprises at least one pharmaceutically acceptable bulking agent.
- 5. The pharmaceutical composition of claim 1, wherein said composition further comprises an expression vector comprising a foreign DNA sequence inserted into the vector.
- 6. The pharmaceutical composition of claim 5, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 7. The pharmaceutical composition of claim 1, wherein said pharmaceutically acceptable carrier is a nonaqueous carrier.
- 8. The pharmaceutical composition of claim 7, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 9. The pharmaceutical composition of claim 7, wherein said composition further comprises an expression vector comprising a foreign DNA sequence inserted into the vector.
- 10. The pharmaceutical composition of claim 9, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 11. The pharmaceutical composition of claim 1, wherein said pharmaceutically acceptable carrier is an aqueous carrier.
- 12. The pharmaceutical composition of claim 11, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 13. The pharmaceutical composition of claim 12, wherein said composition further comprises at least one pharmaceutically acceptable bulking agent.
- 14. The pharmaceutical composition of claim 13, wherein said composition further comprises at least one pharmaceutically acceptable buffering agent.
- 15. The pharmaceutical composition of claim 11, wherein said composition further comprises an expression vector comprising a foreign DNA sequence inserted into the vector.
- 16. The pharmaceutical composition of claim 15, wherein said composition further comprises at least one pharmaceutically acceptable solubilizer.
- 17. The pharmaceutical composition of claim 16, wherein said composition further comprises at least one pharmaceutically acceptable bulking agent.
- 18. The pharmaceutical composition of claim 17, wherein said composition further comprises at least one pharmaceutically acceptable buffering agent.
- 19. A method of treating a disease in a mammal, said method comprising administering a therapeutically effective amount of a pharmaceutical composition comprising SYN3 in combination with a pharmaceutically acceptable carrier.
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. patent application Ser. No. 60/342,329, filed Dec. 20, 2001, the disclosure of which is hereby incorporated by reference in its entirety for all purposes.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60342329 |
Dec 2001 |
US |